Robertson Stephen P. reported AUPH

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001837798-26-000005

Machine-readable

Structured copy

Timestamps

Event (reported)

May 18, 2026

Published

May 20, 2026

Ingested by INSIDER

Nov 5, 03:57 UTC

Last re-read

Nov 5, 03:57 UTC

Extracted facts

Filer

Robertson Stephen P.

Role

Chief Legal Officer

Transaction

Grant or awardAs filed: “A”

Asset

Aurinia Pharmaceuticals Inc.

Ticker

AUPH

Shares

115.5K

Price per share

$0

Execution date (reported)

May 18, 2026

Owned after transaction

621.4K shares

Days from execution to publication

2

What this establishes

Robertson Stephen P. filed this Form 4 reporting a grant or award of AUPH on May 18, 2026. It became public on May 20, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Legal Officer

Robertson Stephen P.cik:0001837798

Issuer

Aurinia Pharmaceuticals Inc.cik:0001600620

Revision history · 0

No field has changed since this record was first ingested.